Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Income Statement [Abstract] | ||||||
| Revenue | $ 6 | $ 117 | $ 17 | $ 117 | $ 496 | |
| Cost of revenue | 6 | 1,013 | 13 | 1,013 | 1,015 | |
| Depreciation | 20 | 1 | 59 | 1 | 14 | |
| Total cost of revenue | 26 | 1,014 | 72 | 1,014 | 1,029 | |
| Gross loss | (20) | (897) | (55) | (897) | (533) | |
| Operating expenses: | ||||||
| Stock-based compensation | 5,130 | 15,675 | 19,710 | 42,346 | ||
| Research and development | 3,018 | 957 | 12,040 | 11,310 | 10,375 | |
| General and administrative | 3,042 | 8,208 | 13,204 | 27,133 | 15,529 | 11,626 |
| Advertising | 12 | 104 | 56 | 284 | 319 | 5,297 |
| Total operating expenses | 3,054 | 11,330 | 14,217 | 39,457 | 46,868 | 69,644 |
| Operating loss | (3,074) | (12,227) | (14,272) | (40,354) | (47,401) | (69,644) |
| Other income (expense): | ||||||
| Impairment of long-lived assets | (1,128) | |||||
| Impairment of held for sale assets, net | (191) | (794) | ||||
| Impairment of investment in Lynx | (975) | (975) | ||||
| Loss on operating lease cancellation | (266) | (266) | ||||
| Other income (expense): | ||||||
| Interest income (expense) | (33) | 72 | (73) | (73) | (7) | |
| Paycheck protection program forgiveness | 397 | |||||
| (Loss) gain on sale or disposal of property and equipment | (531) | (80) | (847) | 30 | 18 | (152) |
| Warrant expense | (984) | (1,020) | ||||
| Gain on convertible debt and warrant liability | 1,903 | 49 | 4,007 | 8,265 | (2,285) | |
| Other income | 45 | 88 | 33 | 33 | 166 | |
| Total other (loss) income, net | (1,918) | 1,790 | (3,801) | 3,013 | 7,223 | (1,881) |
| Net loss | $ (4,992) | $ (10,437) | $ (18,073) | $ (37,341) | $ (40,178) | $ (71,525) |
| Loss per share, basic (in Dollars per share) | $ (0.42) | $ (31.88) | $ (1.75) | $ (160.6) | $ (72.16) | $ (1,347.65) |
| Loss per share, diluted (in Dollars per share) | $ (0.42) | $ (31.88) | $ (1.75) | $ (160.6) | $ (72.16) | $ (1,347.65) |
| Weighted average number of common shares outstanding used in computing loss basic (in Shares) | 11,933,602 | 327,343 | 10,349,618 | 232,505 | 556,826 | 53,074 |
| Weighted average number of common shares outstanding used in computing loss dilued (in Shares) | 11,933,602 | 327,343 | 10,349,618 | 232,505 | 556,826 | 53,074 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The difference between the carrying value and the sale price of an investment. A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|